Browse the evidence

The nuclear receptor NR4A3 is a critical regulator of exercise-induced metabolic responses, including glucose uptake and mitochondrial function, as its silencing ablates these benefits in human muscle cells.

NR4A3 is a key gene that helps muscles respond to exercise by improving glucose uptake and mitochondrial function. While you cannot directly 'dose' this gene, regular exercise upregulates it, thereby enhancing metabolic health.

Adiponectin and members of the TGF-beta superfamily (such as BMP7 and Activin B) regulate adipocyte differentiation, mitochondrial biogenesis, and energy expenditure, serving as potential pharmacotherapeutic targets for obesity.

Hormones like adiponectin and growth factors like BMP7 play key roles in regulating fat storage and energy expenditure. Research into these pathways may lead to new treatments for obesity and diabetes.

Ingestion of short-chain fatty acids (SCFAs), specifically propionate and butyrate, stimulates PYY gene expression and secretion in human enteroendocrine cells via histone deacetylase (HDAC) inhibition, thereby increasing plasma PYY levels.

To maximize your natural PYY production (a hormone that helps you feel full), focus on consuming high-fiber foods that your gut bacteria can ferment into short-chain fatty acids like butyrate and propionate. This process naturally stimulates your gut hormones to regulate appetite, a mechanism that works specifically in humans.

Direct activation of GLP-1 receptors in the ventral tegmental area (VTA) and nucleus accumbens (NAc) core reduces the intake of highly-palatable foods (sucrose and high-fat diet) and body weight, mediated by direct projections from NTS GLP-1 neurons.

This research suggests that GLP-1 medications (like semaglutide or liraglutide) work partly by targeting the brain's reward system (VTA and Nucleus Accumbens) rather than just signaling fullness to the stomach. By dampening the reward signal associated with highly palatable, high-fat, or sugary foods, these drugs reduce the motivation to eat them. This explains why users often find themselves losing interest in junk food specifically, rather than just feeling physically stuffed.

Endogenous GLP-1 signaling in the VTA and NAc core is physiologically necessary to regulate high-fat diet intake, as blocking these receptors leads to increased consumption.

Your brain naturally produces GLP-1 to help keep you from overeating high-fat foods. This study shows that if you block this natural signaling in the reward centers of your brain, you will eat more high-fat food. This suggests that maintaining healthy endogenous GLP-1 signaling (through diet and lifestyle) is important for regulating cravings for palatable foods.

Obesity induces a state of chronic low-grade systemic inflammation driven by adipose tissue macrophage infiltration and pro-inflammatory cytokine release (TNF-α, IL-6, IL-1β), which contributes to insulin resistance and metabolic disease.

Obesity is not just about weight; it triggers a biological inflammatory response that harms metabolic health. Managing weight through diet and exercise can reduce this inflammation and lower the risk of diseases like diabetes and heart disease.

Larger hip circumference is associated with a decreased risk of coronary heart disease, independent of waist circumference and BMI, suggesting a protective metabolic effect of peripheral adiposity.

A larger hip circumference relative to your waist may be protective against heart disease. This suggests that storing fat in the hips and thighs might be metabolically healthier than storing it in the abdomen. Focus on reducing abdominal fat rather than just overall weight.

Evening exposure to blue-enriched light (peak sensitivity ~460-477 nm) suppresses melatonin secretion and shifts circadian phase, with effects occurring rapidly and recovering quickly upon cessation.

If you are sensitive to sleep disruption, minimize exposure to bright, blue-rich light (LEDs, screens) in the 2 hours before bed. Even low levels (5-10 lux) can trigger circadian responses. If you must use light, choose warmer colors (longer wavelengths >600nm) and keep intensity low. Note that effects reverse quickly once the light is off.

Aging causes a chronic, low-grade inflammatory state (inflammaging) driven by senescent cells and immune dysregulation, which impairs vaccine efficacy and increases susceptibility to infection.

As you age, your immune system naturally shifts into a state of chronic, low-grade inflammation (inflammaging) due to the accumulation of senescent cells and altered immune signaling. This state reduces your ability to respond effectively to vaccines and increases infection risk. While you cannot stop aging, maintaining a lean body mass and regular exercise can help reduce the burden of senescent cells and lower pro-inflammatory cytokine levels, potentially preserving some immune function.

The accumulation of senescent cells contributes to inflammaging through the Senescence-Associated Secretory Phenotype (SASP), which releases pro-inflammatory cytokines and chemokines.

Senescent cells, which are 'zombie' cells that stop dividing but don't die, secrete inflammatory signals (SASP) that damage surrounding tissue and drive chronic inflammation. This process is a major driver of age-related decline.

Thymic involution with age leads to a reduced output of naive T cells, resulting in a narrowed T-cell receptor repertoire and impaired ability to mount new immune responses to novel antigens.

As you age, your thymus gland shrinks (involution), producing fewer new naive T cells. This means your immune system has a harder time recognizing and fighting new infections or responding to new vaccines because it lacks the diverse 'tools' (naive T cells) to handle novel threats.

In aging and obese men, elevated sex hormone-binding globulin (SHBG) levels are primarily driven by low growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels, rather than by hyperinsulinism.

If you are older or obese, your low testosterone may be partly due to low Growth Hormone and IGF-1, not just high insulin. Standard weight loss might not fully restore healthy SHBG levels if GH/IGF-1 remains low.

Autophagy is downregulated in the aging heart, and this suppression contributes to cardiac pathology by allowing the accumulation of misfolded proteins and dysfunctional mitochondria.

Maintaining cellular cleanup processes (autophagy) is critical for heart health as you age. While this paper focuses on mechanisms, lifestyle factors known to stimulate autophagy (like caloric restriction or exercise) may help mitigate age-related cardiac decline by preventing the buildup of damaged proteins and mitochondria.

Stimulation of autophagy improves cardiac function in aging hearts by removing accumulated misfolded proteins and dysfunctional mitochondria.

Encouraging autophagy through healthy lifestyle choices may help clear out cellular debris that contributes to heart aging. This suggests that interventions promoting cellular cleanup could be beneficial for long-term heart health.

An earlier age-related onset of obesity (becoming obese before age 20) is independently associated with higher insulin sensitivity and a more favorable lipid profile in obese postmenopausal women.

For obese postmenopausal women, having become obese at a younger age (before 20) may be associated with better insulin sensitivity and lipid profiles compared to those who became obese later in life. This highlights the importance of fat distribution and timing of obesity onset, not just current weight or duration of obesity.

Elevating forearm insulin to high physiologic levels (approx. 157 uU/ml) blocks approximately 74% of skeletal muscle amino acid nitrogen release in postabsorptive humans, primarily by inhibiting the output of branched-chain and aromatic amino acids.

In a fasted state, raising insulin levels significantly stops muscle from breaking down and releasing most amino acids (like leucine and isoleucine) into the blood. However, this effect is not universal; alanine release continues largely unchanged. This suggests insulin's primary job in fasting is to preserve muscle protein by stopping its breakdown, rather than actively building new muscle tissue from scratch.

Doubling basal insulin levels (low-dose infusion) is sufficient to block free fatty acid release from adipose tissue but is often insufficient to block amino acid release from muscle, indicating different sensitivity thresholds for these metabolic pathways.

Low levels of insulin are enough to stop your fat cells from releasing fatty acids, but they are often not enough to stop your muscles from releasing amino acids. To significantly reduce muscle protein breakdown, you likely need higher insulin levels or other strategies, as low-level insulin elevation primarily targets fat metabolism.

Skeletal muscle-specific ablation of the core clock gene Bmal1 causes impaired insulin-stimulated glucose uptake and reduced glucose oxidation, primarily through reduced protein levels of GLUT4 and TBC1D1 and altered pyruvate dehydrogenase (PDH) activity.

Your muscles have an internal clock that prepares them to process glucose efficiently during your active/feeding phases. Disrupting this rhythm (e.g., through irregular sleep or eating times) may impair your muscles' ability to take up glucose in response to insulin, even if you are not overweight. Maintaining consistent sleep and meal timing supports optimal muscle insulin sensitivity.

Central fat distribution (waist circumference and waist-to-hip ratio) is an independent negative predictor of serum adiponectin levels, stronger than overall adiposity (BMI or total fat mass).

If you want to support healthy adiponectin levels, focus on reducing abdominal fat (waist circumference) rather than just total body weight. Central fat is a stronger determinant of low adiponectin than overall obesity.

Acute fasting (48 hours) and leptin administration (physiological or pharmacological doses) do not alter serum adiponectin levels in healthy humans.

Short-term fasting (48 hours) or taking leptin supplements will not change your blood levels of adiponectin. Do not expect these interventions to boost adiponectin directly.

Serum estradiol is an independent negative predictor of serum adiponectin levels, explaining higher adiponectin in postmenopausal women compared to premenopausal women.

Lower estrogen levels (as seen in menopause) are associated with higher adiponectin. This is an independent factor from body fat.

Adipose tissue functions as an active immunological organ during obesity, where expansion triggers chronic low-grade inflammation via immune cell infiltration and DAMP sensing, leading to systemic insulin resistance and metabolic syndrome.

Obesity is not just about storing excess calories; it triggers an immune response in fat tissue that causes insulin resistance. This means that simply losing weight without addressing the underlying inflammation might not fully restore metabolic health, and long-term weight maintenance is crucial to resolving this immune activation.

Macrophage polarization from anti-inflammatory M2 to pro-inflammatory M1 phenotypes in adipose tissue is a key driver of insulin resistance, driven by the sensing of metabolic danger signals (DAMPs) like free fatty acids and uric acid.

The type of immune cells in your fat matters. In obesity, fat tissue fills with pro-inflammatory M1 macrophages that release chemicals blocking insulin action. Weight loss can help restore these cells to a healthier, anti-inflammatory state, but this process may take time and requires sustained weight stability.

Birth weight is strongly predictive of later lean mass but has a much weaker association with later fatness, contradicting the historical view that large babies simply become obese adults.

Don't assume a large baby will inevitably be an obese adult. Birth weight is a better predictor of future muscle mass (lean mass) than fat mass. Focus on healthy postnatal growth rather than worrying solely about birth size for obesity risk.